A prospective, observational, multicenter study assessing the iobavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients
Latest Information Update: 06 Dec 2021
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- Acronyms the better study
- Sponsors Chiesi Espana
- 06 Dec 2021 New trial record
- 01 Dec 2021 Results published in the Clinical Transplantation